Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Alliance to study use of magnetic resonance focused ultrasound to eliminate breast tumors
December 29th, 2005
InSightec, Ltd. is partnering with the American College of Radiology Imaging Network (ACRIN) to enroll patients in a phase II study assessing how effectively the ExAblate 2000 technology can ablate, or destroy, cancerous breast tumors. If effective, this outpatient procedure could become a potential non-invasive treatment alternative to lumpectomies or surgical removal of breast tumors and the surrounding area of normal tissue. The ExAblate 2000 combines magnetic resonance imaging (MRI) with highly-focused ultrasound to non-invasively thermally ablate (destroy) tumors in the body. Currently, the technology is used to treat uterine fibroids, a benign...
Source: Women's Health Weekly (2005-12-29)
|
